Factors associated with concurrent malignancy risk among patients with incidental solitary pulmonary nodule: A systematic review taskforce for developing rapid recommendations-Reference-Cited by-同舟云学术

Factors associated with concurrent malignancy risk among patients with incidental solitary pulmonary nodule: A systematic review taskforce for developing rapid recommendations

Published:2022-06 Issue:2 Volume:15 Page:106-122
ISSN:1756-5383
Container-title:Journal of Evidence-Based Medicine
language:en
Short-container-title:J Evidence Based Medicine

Author:

Zhu Yuqi¹^ORCID,Yang Lan¹^ORCID,Li Qianrui²^ORCID,Chen Bojiang¹^ORCID,Hao Qiukui³⁴^ORCID,Sun Xin²^ORCID,Tan Jing²^ORCID,Li Weimin¹^ORCID

Affiliation:

1. Department of Respiratory and Critical Care Medicine West China Hospital of Sichuan University Chengdu China

2. Chinese Evidence‐Based Medicine Center Cochrane China Center and MAGIC China Center West China Hospital Sichuan University Chengdu China

3. The Center of Gerontology and Geriatrics National Clinical Research Center for Geriatrics West China Hospital Sichuan University Chengdu China

4. School of Rehabilitation Science McMaster University Hamilton Ontario Canada

Publisher

Wiley

Subject

Health Policy,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jebm.12481

Reference58 articles.

1. Cancer Statistics, 2021

2. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US

3. Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on surveillance, epidemiology, and end results (SEER) database

4. Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer

5. Diagnosis and management of peripheral lung nodule

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignancy risk stratification for solitary pulmonary nodule: A clinical practice guideline;Journal of Evidence-Based Medicine;2022-06